Literature DB >> 19647035

Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.

Mamdouh H Kedees1, Marine Grigoryan, Yelena Guz, Gladys Teitelman.   

Abstract

Glucose homeostasis is determined by a balance between insulin and glucagon, produced by beta and alpha cells of the pancreas respectively. The levels of circulating hormones is partly determined by the mass of these two endocrine cell types. However, in contrast to beta cells, the identity of the signals regulating alpha cell number is not known. Mice with a global deletion of the glucagon receptor (Gcgr-/-) and mice with ablation of prohormone convertase 2 (PC2), the enzyme involved in the conversion of proglucagon into mature glucagon, develop alpha cell hyperplasia. These observations and the fact that Gcgr-/- mice exhibit high levels of circulating glucagon-like peptide-1 (GLP-1) suggested that members of the glucagon family of peptides could be directly involved in the regulation of alpha cell number. In this study we sought to determine whether alpha cells express receptors for Glucagon (Gcgr) and/or the glucagon-like peptide-1 (GLP1r). We examined the expression of these receptors in islets of Gcgr-/-, PC2-/- mice and control littermates, in an alpha (alphaTC1/9) and in a beta (betaTC3) cell line. Gcgr was expressed exclusively by islet beta cells, but not by alpha cells, of the two lines of mice lacking glucagon signaling. Similarly, betaTC but not alphaTC cells, expressed Gcgr. The expression of GLP1r by alpha cells was determined by the genotype and age of the mice. In embryos, GLU+ cells of Gcgr+/+ mice cells express GLP1r during early development, but not in adults. In contrast, alpha cells of Gcgr-/- mice were GLP1r+ throughout life, reflecting the immature state of GLU+ cells when Gcgr is deleted. Unlike alpha cells, beta cells of all mice lines examined initiate GLP1r expression after birth. These results suggest that GLP-1 may affect the maturation of postnatal but not prenatal beta cells. In addition, they also suggest that the incretin could mediate alpha cell proliferation, inducing the development of alpha cell hyperplasia in Gcgr-/- mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647035      PMCID: PMC2743461          DOI: 10.1016/j.mce.2009.07.024

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  46 in total

1.  Comparison of cytokine effects on mouse pancreatic alpha-cell and beta-cell lines. Viability, secretory function, and MHC antigen expression.

Authors:  K Hamaguchi; E H Leiter
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

2.  Glucagon receptors in -cells. Binding of 125 I-glucagon and activation of adenylate cyclase.

Authors:  I D Goldfine; J Roth; L Birnbaumer
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

Review 3.  Role of islet cell antibodies in the pathogenesis of type I diabetes.

Authors:  C H Brogren; S Baekkeskov; T Dyrberg; A Lernmark; B Marner; J Nerup; G K Papadopoulos
Journal:  Curr Probl Clin Biochem       Date:  1983

4.  In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.

Authors:  C M Asplin; T L Paquette; J P Palmer
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

5.  Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.

Authors:  Juan Carlos Lopez-Talavera; Adolfo Garcia-Ocaña; Ian Sipula; Karen K Takane; Irene Cozar-Castellano; Andrew F Stewart
Journal:  Endocrinology       Date:  2003-10-09       Impact factor: 4.736

6.  Abrogation of protein convertase 2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis.

Authors:  M Vincent; Y Guz; M Rozenberg; G Webb; M Furuta; D Steiner; G Teitelman
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

7.  Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse.

Authors:  R V Campos; Y C Lee; D J Drucker
Journal:  Endocrinology       Date:  1994-05       Impact factor: 4.736

8.  Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture.

Authors:  Z Ling; J C Hannaert; D Pipeleers
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

9.  Insulin within islets is a physiologic glucagon release inhibitor.

Authors:  H Maruyama; A Hisatomi; L Orci; G M Grodsky; R H Unger
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide.

Authors:  G Teitelman; S Alpert; J M Polak; A Martinez; D Hanahan
Journal:  Development       Date:  1993-08       Impact factor: 6.868

View more
  18 in total

1.  Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis.

Authors:  Huw B Jones; Jaimini Reens; Simon R Brocklehurst; Catherine J Betts; Sue Bickerton; Alison L Bigley; Richard P Jenkins; Nicky M Whalley; Derrick Morgan; David M Smith
Journal:  Int J Exp Pathol       Date:  2014-02       Impact factor: 1.925

2.  Glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis.

Authors:  Lihua Ye; Morgan A Robertson; Daniel Hesselson; Didier Y R Stainier; Ryan M Anderson
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

Review 3.  α-cell role in β-cell generation and regeneration.

Authors:  Joel F Habener; Violeta Stanojevic
Journal:  Islets       Date:  2012 May-Jun       Impact factor: 2.694

Review 4.  A synopsis of factors regulating beta cell development and beta cell mass.

Authors:  Krishna Prasadan; Chiyo Shiota; Xiao Xiangwei; David Ricks; Joseph Fusco; George Gittes
Journal:  Cell Mol Life Sci       Date:  2016-04-22       Impact factor: 9.261

5.  Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.

Authors:  Sarah Noerklit Roed; Anne Cathrine Nøhr; Pernille Wismann; Helle Iversen; Hans Bräuner-Osborne; Sanne Moeller Knudsen; Maria Waldhoer
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

Review 6.  Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models.

Authors:  P M Vuguin; M J Charron
Journal:  Diabetes Obes Metab       Date:  2011-10       Impact factor: 6.577

7.  Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.

Authors:  Chunhua Dai; Yan Hang; Alena Shostak; Greg Poffenberger; Nathaniel Hart; Nripesh Prasad; Neil Phillips; Shawn E Levy; Dale L Greiner; Leonard D Shultz; Rita Bottino; Seung K Kim; Alvin C Powers
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

8.  PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist.

Authors:  Taichi Nakamura; Tetsuhide Ito; Masahiko Uchida; Masayuki Hijioka; Hisato Igarashi; Takamasa Oono; Masaki Kato; Kazuhiko Nakamura; Koichi Suzuki; Robert T Jensen; Ryoichi Takayanagi
Journal:  Lab Invest       Date:  2013-11-11       Impact factor: 5.662

9.  Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish.

Authors:  Mingyu Li; E Danielle Dean; Liyuan Zhao; Wendell E Nicholson; Alvin C Powers; Wenbiao Chen
Journal:  J Endocrinol       Date:  2015-11       Impact factor: 4.286

10.  Regulation of mouse intestinal L cell progenitors proliferation by the glucagon family of peptides.

Authors:  Marine Grigoryan; Mamdouh H Kedees; Maureen J Charron; Yelena Guz; Gladys Teitelman
Journal:  Endocrinology       Date:  2012-05-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.